CorticorpNews
Back to Finance
Expand

JoachimKohler-HB · CC BY-SA 4.0 · Wikimedia Commons

Updated

Novartis raised its peak sales forecasts for blockbuster drugs to $18 billion, CNBC Top News reported on November 19, 2026, citing strong demand. The upgrades cover medicines for multiple sclerosis, leukemia and cholesterol. The company is seeking to show that its growth can last. The available excerpt gave no share price reaction or revised figures for individual products.

1 outlet · 1 article · first seen Nov 19, 7:04 AM ET

What this touches in markets

Stored closes for the instruments tied to this story's tags and places, with their dates.

  • XLV closed at 181.17, down 2.20%, on 2026-11-18. Listed for: Health Care sector ETF.

Every source article